切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 106 -110,146. doi: 10.3877/cma.j.issn.1674-3253.2022.02.003

临床研究

MRI 3D-LAVA动态增强联合FRFSE序列诊断早期前列腺癌的效能
刘成环1,(), 李俊华1, 祁海峰1, 龚晓萍1   
  1. 1. 810000 青海,西宁市第一人民医院放射科
  • 收稿日期:2020-11-02 出版日期:2022-04-01
  • 通信作者: 刘成环

Diagnosis of early prostate cancer by MRI of 3D-LAVA dynamic enhancement combined with FRFSE sequence

Chenghuan Liu1,(), Junhua Li1, Haifeng Qi1, Xiaoping Gong1   

  1. 1. Department of Radiology, the First People's Hospital of Xining City, Qinghai 810000, China
  • Received:2020-11-02 Published:2022-04-01
  • Corresponding author: Chenghuan Liu
引用本文:

刘成环, 李俊华, 祁海峰, 龚晓萍. MRI 3D-LAVA动态增强联合FRFSE序列诊断早期前列腺癌的效能[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(02): 106-110,146.

Chenghuan Liu, Junhua Li, Haifeng Qi, Xiaoping Gong. Diagnosis of early prostate cancer by MRI of 3D-LAVA dynamic enhancement combined with FRFSE sequence[J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(02): 106-110,146.

目的

探讨核磁共振成像(MRI)三维容积内插快速扰相梯度回波序列(3D-LAVA)屏气检查动态增强联合快速翻转快速自旋回波序列(FRFSE)对早期前列腺癌的诊断效能。

方法

对我院2013年6月至2019年6月210例可疑早期前列腺癌的临床资料进行回顾,均实施MRI 3D-LAVA动态增强、FRFSE序列扫描。总结两种扫描序列的检查结果,分析不同方法诊断早期前列腺癌的效能;另统计多参数磁共振(mpMRI)的诊断结果,绘制受试者工作特征曲线(ROC)评价不同方法诊断早期前列腺癌的效能。

结果

早期前列腺癌的构成比为38.10%;早期前列腺癌(+)患者峰值和强化率均高于前列腺癌(-)受检者,且早期前列腺癌(+)患者峰值时间短于后者,强化幅度小于后者,差异均有统计学意义(P<0.05);MRI 3D-LAVA动态增强联合FRFSE序列诊断早期前列腺癌的灵敏度与MRI 3D-LAVA动态增强、FRFSE序列单独诊断相近,特异度、准确度和曲线下面积(AUC)均高于单独诊断;MRI 3D-LAVA动态增强联合FRFSE序列诊断早期前列腺癌的灵敏度、特异度、准确度均与mpMRI相当,且二者AUC对比差异无统计学意义(P>0.05)。

结论

在早期前列腺癌诊断中MRI 3D-LAVA动态增强、FRFSE序列扫描联合检查的效能理想,与病理结果的一致性良好,和mpMRI诊断早期前列腺癌的效能相近。

Objective

To explore the diagnostic efficacy of three-dimensional MRI GRE sequence (3D-LAVA) gas-screen examination and fast recovery fast spin echo sequence (FRFSE) in early prostate cancer by magnetic resonance imaging (MRI).

Methods

The clinical data of 210 suspected cases of early prostate cancer in our hospital from June 2013 to June 2019 were reviewed. MRI 3D-LAVA and FRFSE sequence scanning were performed in all cases. The results of two scanning sequences were summarized and the efficacy of different methods in the diagnosis of early prostate cancer was analyzed. In addition, the diagnosis results of multi-parameter magnetic resonance imaging (mpMRI) were compared, and the receiver operating characteristic curve (ROC) was drawn to evaluate the efficacy of different methods in the diagnosis of early prostate cancer.

Results

The ratio of early prostate cancer was 38.10%. The peak value and enhancement rate of early prostate cancer (+) patients were higher than those of prostate cancer (-) patients, and the peak time of early prostate cancer (+) patients was shorter than that of the latter, and the enhancement extent was smaller than that of the latter, the difference was statistically significant (P<0.05). The sensitivity of MRI 3D-LAVA dynamic enhancement combined with FRFSE sequence in the diagnosis of early prostate cancer was similar of MRI 3D-LAVA dynamic enhancement and FRFSE sequence alone, and the specificity, accuracy and AUC were higher than those of single diagnosis. The sensitivity, specificity and accuracy of 3D-LAVA dynamic contrast-enhanced MRI combined with FRFSE sequence in the diagnosis of early prostate cancer were comparable of mpMRI, and there was no significant difference in AUC between the two groups (P>0.05).

Conclusion

In the diagnosis of early prostate cancer, the efficiency of combination of 3D-LAVA dynamic enhancement and FRFSE sequence scanning is effective, which is in good agreement with pathological results, and is similar of mpMRI in the diagnosis of early prostate cancer.

图1 病例入组流程图
表1 不同MRI序列扫描检查的诊断结果(例)
表2 不同早期前列腺癌发生情况MRI 3D-LAVA动态增强SI-T曲线参数对比(±s)
图2 不同方法诊断早期前列腺癌的ROC曲线
图4 一例早期前列腺癌患者的MRI
表3 不同方法诊断早期前列腺癌的效能分析(%)
[1]
兰蓝, 赵飞, 蔡玥, 等. 中国居民2015年恶性肿瘤死亡率流行病学特征分析[J]. 中华流行病学杂志, 2018, 39(1): 32-34.
[2]
Koo KC, Lee JS, Kim JW, et al. Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis [J]. BMC Cancer, 2018, 18(1): 468.
[3]
Salembier C, Villeirs G, De Bari B, et al. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer [J]. Radiother Oncol, 2018, 127(1): 49-61.
[4]
Manfredi M, Mele F, Garrou D, et al. Multiparametric prostate MRI: technical conduct, standardized report and clinical use [J]. Minerva Urol Nefrol, 2018, 70(1): 9-21.
[5]
Brown LC, Ahmed HU, Faria R, et al. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study [J]. Health Technol Assess, 2018, 22(39): 1-176.
[6]
Coker MA, Glaser ZA, Gordetsky JB, et al. Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy [J]. Prostate Cancer Prostatic Dis, 2018, 21(4): 549-555.
[7]
张凯, 张志鹏, 朱刚, 等. 两种核磁靶向穿刺诊断有临床意义前列腺癌精确性的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(5): 293-296.
[8]
王慧慧, 何群, 沈棋, 等. 多参数MRI对前列腺癌包膜侵犯的诊断价值[J]. 实用放射学杂志, 2018, 34(4): 556-559.
[9]
Sherrer RL, Lai WS, Thomas JV, et al. Incidental findings on multiparametric MRI performed for evaluation of prostate cancer [J]. Abdom Radiol (NY), 2018, 43(3): 696-701.
[10]
Yarlagadda VK, Lai WS, Gordetsky JB, et al. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men [J]. Diagn Interv Radiol, 2018, 24(3): 115-120.
[11]
Kim JG, Kim CK, Kim JH. Prebiopsy multiparametric mri with cancer-negative findings in men with suspected prostate cancer: evaluation using prostate imaging reporting and data system version 2 [J]. AJR Am J Roentgenol, 2018, 211(1): 121-126.
[12]
Li P, You S, Nguyen C, et al. Genes involved in prostate cancer progression determine MRI visibility [J]. Theranostics, 2018, 8(7): 1752-1765.
[13]
冼土增, 张俊夫, 罗飞, 等. 多参数磁共振成像联合四基因模型提高前列腺癌早期诊断效能的临床研究[J]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(3): 11-15.
[1] 方晔, 谢晓红, 罗辉. 品管圈在提高前列腺癌穿刺检出率中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(07): 722-727.
[2] 曹建辉, 徐栋, 冯斌, 郑俊彪, 黄伟伟. 超声造影在不同前列腺特异抗原含量前列腺癌穿刺活检中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(03): 307-312.
[3] 李全喜, 唐辉军, 张健生, 杨飞. 基于MUSE-DWI与SS-DWI技术在前列腺癌图像中的对比研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 553-557.
[4] 梅津熠, 王燕, 瞿旻, 董振阳, 周增辉, 沈显琦, 李嘉伦, 高旭. 机器人前列腺癌根治术中"膀胱外中叶"的处理[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 429-433.
[5] 穆靖军, 马增妮, 曹晓明. 临床局限性前列腺癌包膜外侵犯的危险因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 326-331.
[6] 李全喜, 唐辉军, 唐友杰, 杨飞. DISCO成像技术在前列腺增生与前列腺癌鉴别诊断中的应用价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 332-335.
[7] 王邦郁, 陈晓鹏, 唐国军, 王佳妮. 尿液细胞外囊泡circRNA分类器对高级别前列腺癌诊断价值的初步研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 339-342.
[8] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[9] 南方护骨联盟前列腺癌骨转移专家组. 前列腺癌骨转移诊疗专家共识(2023版)[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 201-208.
[10] 倪鑫淼, 王磊, 王潇, 陈志远, 翁小东, 刘修恒. 前列腺癌患者骨保护现状及临床用药进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 191-195.
[11] 刘容, 翁铭芳, 郭春雨, 邱仁慧, 方潇, 贺立民, 邓震. 机器人辅助与普通腹腔镜前列腺癌根治术对老年患者尿控功能的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 169-172.
[12] 秦国强, 卢旭, 张朝枫, 罗欣, 李杰贤, 邹戈, 江福能. 超声造影经直肠前列腺靶向穿刺活检术在PSA 4~10 ng/ml患者中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 36-38.
[13] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[14] 王苏贵, 皇立媛, 姜福金, 吴自余, 张先云, 李强, 严大理. 异质性细胞核核糖蛋白A2B1在前列腺癌中的作用及其靶向中药活性成分筛选研究[J]. 中华临床医师杂志(电子版), 2023, 17(06): 731-736.
[15] 王志文, 郑雪梅, 张庆坤, 王海江. 自发性低颅压综合征75例临床分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 398-401.
阅读次数
全文


摘要